Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis-Reference-Cited by-同舟云学术

Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis

Published:2021-05-13 Issue:12 Volume:56 Page:3634-3643
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Ochs Madeleine A.¹^ORCID,Dillman Nicholas O.¹^ORCID,Caverly Lindsay J.²^ORCID,Chaffee Valerie D.³^ORCID

Affiliation:

1. Department of Pharmacy Services and Clinical Pharmacy Michigan Medicine Ann Arbor Michigan USA

2. Department of Pediatrics University of Michigan Medical School Ann Arbor Michigan USA

3. Department of Pharmacy Cancer and Hematology Centers of West Michigan Grand Rapids Michigan USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25441

Reference66 articles.

1. Cystic Fibrosis Foundation.Patient registry: annual data report.Cystic Fibrosis Foundation;2011.http://www.cysticfibrosisdata.org/LiteratureRetrieve.aspx?ID=132652

2. Cystic Fibrosis Foundation.Patient registry: annual data report.Cystic Fibrosis Foundation;2019.https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf

3. Cystic Fibrosis Foundation.Patient Registry: annual data report.Cystic Fibrosis Foundation;2017.https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf

4. Cystic Fibrosis Pulmonary Guidelines

5. Tobramycin and Beta-Lactam Antibiotic Use in Cystic Fibrosis Exacerbations: A Pharmacist Approach

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction to therapeutic drug monitoring;Therapeutic Drug Monitoring;2024

2. Therapeutic drug monitoring-guided dosing for pediatric cystic fibrosis patients: recent advances and future outlooks;Expert Review of Clinical Pharmacology;2023-07-21

3. Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung function;Respiratory Medicine;2023-06

4. New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis;Therapeutic Drug Monitoring;2023-04

5. Pseudomonas aeruginosa Phosphate Transporter PitA (PA4292) Controls Susceptibility to Aminoglycoside Antibiotics by Regulating the Proton Motive Force;Antimicrobial Agents and Chemotherapy;2022-12-20